Another factor implicated in the aetiology of preterm birth is sexually transmitted infection (STI). The incidence of STI is high among Indigenous Australians. The notification rate of chlamydia for Indigenous Australians (1341 per 100 000) is three times higher than for non-Indigenous Australians (389 per 100 000). 8 For gonorrhoea, the rate is 18 times higher (859 vs 49
per 100 000). 8 Research into whether the high rates of STI and prematurity are linked has produced diverse results and mainly preceded the availability of sensitive nucleic acid amplification testing (NAAT).
5-7,9
The aim of this study was to evaluate the relationship between antenatal STI and preterm birth in Indigenous women of the Northern Territory, Australia. It was hypothesised that the proportion of STI diagnoses would be higher among cases of preterm birth than among term pregnancies.
MATERIALS AND METHODS
A retrospective case-control study was conducted of Indigenous women who gave birth at the Royal Darwin Hospital (RDH),
Australia, between 1 January, 2011 and 31 December, 2014 inclusive.
Births to Indigenous women were identified from the institution's birth registry. Indigenous status is usually determined by self-report or a woman's own birth registration data. Cases were defined as singleton births at <37 weeks gestation. Exclusion criteria were multiple pregnancy, stillbirth, birth before arrival to hospital or in the midwifery-led birth centre, infant major congenital abnormality or if the paper medical records were not accessible for review. Controls were defined as singleton births at or beyond 37 weeks gestation with the same exclusion criteria.
The prevalence of antenatal STI was estimated at 25%. 5, 10 It was calculated that a sample size of 324 births per group was needed to detect an exposure rate difference of 10% with 80% power at a two-sided significance level of five percent. It was predicted that a four-year period (2011-2014) would provide sufficient cases.
All eligible cases from the study period were included. An equal number of controls were chosen by computerised random selection, matched for month and year of delivery to minimise bias from seasonal variation in STI prevalence and preterm rupture of membranes and birth. 11 If medical records for a control were not available, another was selected by the same method.
The main exposure of interest was any diagnosis of chlamydia, gonorrhoea, trichomonas or syphilis in pregnancy. and antepartum haemorrhage. [5] [6] [7] Factors that were associated with preterm birth on univariate analysis at P < 0.25 were also included if they were plausible confounders. The matching variables of month and year of delivery were not included in the regression models and missing data were excluded list-wise. Significance was defined as P < 0.05. Secondary analyses were performed for spontaneous preterm births and births at <34 weeks gestation. 
RESULTS
From 2011 to 2014 there were 2349 singleton live births to Indigenous women at the institution (Fig. 1 ). Of these births, 400
(17%) were preterm. After exclusion of three cases for major infant anomalies, 17 of the remainder (4.3%) were excluded for inaccessible records, leaving 380 cases. In reaching the same number of controls, 37 (8.9%) were excluded for inaccessible records. There were 20 women among cases and nine among controls who had two births included in those categories, and six women had births included for both a case and control. NAAT for STI was performed at least once for 91.3% of pregnancies.
Controls and cases were similar in age, ethnicity and parity (Table 1 ). In addition to pre-specified potential confounders, the variables remoteness and pregnancy dating method were significantly associated with preterm birth and selected for logistic regression analysis.
Smoking status and antenatal care frequency were missing for 6.3% and 2.6% of pregnancies, respectively, with no statistically significant difference between cases and controls. For remaining variables, <2.5% of data were missing. The remoteness categories
Inner and Outer Regional were merged.
There were 162 STIs diagnosed in 140 pregnancies, with an overall exposure rate of 18.4%. Compared to non-exposed pregnancies, STI in pregnancy was not associated with preterm birth (exposure rate 18.4% in both controls and cases, OR 1, 95%CI 0.69-1.44). This was unchanged by adjustment for confounders (adjusted OR (aOR) 0.9, 95%CI 0.58-1.39). In the secondary analysis of spontaneous births (n = 476) and compared with non-exposed pregnancies, the risk of preterm Of women with an STI, 59.3% commenced treatment more than a week before birthing, with no difference between cases and controls (55.7% and 62.9%, respectively, P = 0.39). Table 3 summarises treatment timing by infection type for both groups.
The frequency of previous syphilis and hepatitis B is shown in Table 1 . There were no new HIV diagnoses.
DISCUSSION
In this case-control study of Australian Indigenous women, the composite of any STI in pregnancy was not associated with preterm birth. A diagnosis of gonorrhoea (but not chlamydia or trichomonas) did appear to increase the risk of preterm birth. Thirty-seven paper records of potential controls were not accessible in reaching the target.
All births n = 7311
Births to non-Indigenous women n = 4895
Births to Indigenous women n = 2416
Singleton live births n = 2349
Gestation <37 weeks n = 400 The relationship of STI and preterm birth has been extensively examined. It is proposed that genital infection may trigger local release of cytokines, metalloprotease and prostaglandins that activate partrition pathways. 13, 14 Published studies differ in population characteristics, STI prevalence, testing methods and confounder selection and results have been non-conclusive.
Cases
n = 380 (361 women) Excluded: Major congenital anomaly n = 3 Paper record not accessible n = 17 Gestation 37 weeks n = 1947 Controls n = 380 (372 women) Excluded: Twin births n = 41 FDIU n = 26
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The highest quality research in the Indigenous population comes from a series in urban Queensland by Panaretto and colleagues. 6, 10 In their prospective analysis of 456 pregnancies, overall or individual genital infections were not associated with preterm birth. As with our research, the inclusion of iatrogenic preterm births may have affected this finding. We intentionally included iatrogenic births so that potentially infection-related conditions (e.g. chorioamnionitis) were not excluded. However, preterm births indicated for conditions unlikely to be infection- composite exposure variable may have obscured unique effects of different bacteria.
Comparison with earlier studies in Indigenous Australian populations, including at our institution 5 and in Western Australia, 7, 9 is limited by their use of proxy measures of preterm gestation, heterogenous definitions of genitourinary infection and non-NAAT methods.
Women with gonorrhoea in pregnancy had increased risks of preterm birth (aOR 2.92, 95%CI 1.07-7.97). The association persisted in the secondary analyses of spontaneous births and preterm births at less than 34 weeks gestation. While the low number of events mandate caution in interpreting the result, it concurs with population and case-control studies. 16, 17, 21 This association may be causative, related to ascending infection and the numerous invasion mechanisms of the gonococcus.
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Causation may also result from the polymorphonucleocyte-rich inflammatory response induced by gonorrhoea. 22 Alternatively, gonorrhoea infection may denote (rather than cause) high obstetric risk. In an Australian population study, women with gonorrhoea (or chlamydia) prior to pregnancy had increased risks of subsequent preterm birth. 23 This highlights a possible proxy relationship or chronic inflammatory effect. The interval between diagnosis and treatment was not examined and may have been contributory. For both cases and controls, the majority of gonorrhoea diagnoses were treated more than a week prior to birthing (Table 3) .
We did not find an association between antenatal chlamydia infection and preterm birth. Previous investigations into chlamydia and preterm birth have yielded diverse results. 20, [24] [25] [26] For example, the Preterm Prediction Study reported that chlamydia infection at 24 weeks gestation increased the risk of spontaneous preterm birth, 24 while a subsequent larger observational analysis by the same authors found no association. 20 Gestational age and acuity of chlamydia infection may alter risks of prematurity and membrane rupture. 21, 27 These factors were not accounted for in our study.
Trichomonas was also not associated with preterm birth.
Observational data have reported a slight increased risk of prematurity with trichomonas; however, potential publication bias has been highlighted. 28 Of note, a randomised controlled trial of women with antenatal trichomonas showed significantly higher rates of preterm birth among women treated with metronidazole than with placebo. 29 Hypotheses for this phenomenon included release of inflammatory products from failing trichomonads, and chance observation. In our institution, trichomonas treatment is deferred until 36 weeks gestation unless symptomatic. A similar number of cases and controls received trichomonas treatment before 36 weeks gestation (Table 3 ). In the secondary analysis, women with trichomonas had lower risks of preterm birth before 34 weeks gestation compared with non-exposed women.
Conclusions must be limited from this analysis; however, the observation questions the role of trichomonas as a risk factor for preterm birth.
A strength of the research is the representation of the study population. Sampling bias was minimised by the inclusion of all preterm births across the four-year study period, random selection of controls and the exclusion of only a small proportion of eligible pregnancies due to inaccessible records. With the large sample size and the fact that the majority of preterm births in the area occur at this institution, we believe this sample accurately represents the characteristics and outcomes of Indigenous women birthing in this region of Australia.
Overall there were high rates of data completeness, including NAAT for STI for more than 90% of pregnancies. The exception was smoking status which was missing for 6.3%. With list-wise deletion of missing data, our sample size for the primary and secondary analyses was reduced to 685. Additionally, in our power calculations we assumed more frequent STI exposure than was observed, meaning our sample size may have been insufficient to detect smaller differences. These factors present the possibility of a type II error.
Ultrasound was performed before 15 weeks gestation in only 52% of pregnancies. Some cases and controls may therefore have been inaccurately assigned due to imprecise dating. To account for possible confounding from this source, pregnancy dating method was included in the regression analyses.
Our study presents important observational data about the sexual and obstetric health of this cohort. The high preterm birth rate exceeds the national Indigenous average. Women's Business.
